The corresponding model parameter CD34 ratio reflects these cell population changes during CML hematopoiesis, where, over time, CD34+ blasts outnumber differentiated and committed CD34− cells. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.